Skip to content

13G filed by Jiangsu Hengrui Pharmaceuticals Co., Ltd.

Jiangsu Hengrui Pharmaceuticals Co., Ltd. reported 7,420,091 BRVE shares, 8.2% of the class, as of 2026-09-30, in a 13G accepted by EDGAR 2026-11-09 11:02:30 UTC.

Accession
0001104659-26-124063
Filer
CIK 2080343
Filed
2026-11-09
Accepted by EDGAR
Ingested
Source
EDGAR live feed

Original filing

Stake

Shares
7,420,091
Percent of class
8.2%
Event date
2026-09-30

How the shares relate across the reporting persons: one reporting person counts. The page shows the largest row.

Reporting persons

PersonTypeSole votingShared votingSole dispositiveShared dispositiveAggregatePercent
Jiangsu Hengrui Pharmaceuticals Co., Ltd.CO7,420,09107,420,09107,420,0918.2%